Cost Effectiveness of Long-Term Incobotulinumtoxin-A Treatment in the Management of Post-stroke Spasticity of the Upper Limb from the Australian Payer Perspective

[1] Esquenazi A(2011)The human and economic burden of poststroke spasticity and muscle overactivity J Clin Outcomes Manag. 18 607-614

[2] Brashear A(2002)Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke N Engl J Med 347 395-400

[3] Gordon MF(2004)Spasticity after stroke—its occurrence and association with motor impairments and activity limitations Stroke 35 134-140

[4] Elovic E(2002)Prevalence of spasticity post stroke Clin Rehabil. 16 515-522

[5] Sommerfeld DK(2009)European consensus table on the use of botulinum toxin type A in adult spasticity J Rehabil Med. 41 13-25

[6] Eek E(2016)Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology Neurology. 86 1818-1826

[7] Svensson AK(2012)Poststroke spasticity management Stroke 43 3132-3136

[8] Watkins CL(2009)Efficacy and safety of botulinum neurotoxin NT 201 in post-stroke upper limb spasticity Clin Neuropharmacol 32 259-265

[9] Leathley MJ(2011)Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity J Rehabil Med 43 486-492

[10] Gregson JM(2016)Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity Muscle Nerve Mar. 53 415-421

[1] Esquenazi A(2011)The human and economic burden of poststroke spasticity and muscle overactivity J Clin Outcomes Manag. 18 607-614

[2] Brashear A(2002)Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke N Engl J Med 347 395-400

[3] Gordon MF(2004)Spasticity after stroke—its occurrence and association with motor impairments and activity limitations Stroke 35 134-140

[4] Elovic E(2002)Prevalence of spasticity post stroke Clin Rehabil. 16 515-522

[5] Sommerfeld DK(2009)European consensus table on the use of botulinum toxin type A in adult spasticity J Rehabil Med. 41 13-25

[6] Eek E(2016)Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology Neurology. 86 1818-1826

[7] Svensson AK(2012)Poststroke spasticity management Stroke 43 3132-3136

[8] Watkins CL(2009)Efficacy and safety of botulinum neurotoxin NT 201 in post-stroke upper limb spasticity Clin Neuropharmacol 32 259-265

[9] Leathley MJ(2011)Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity J Rehabil Med 43 486-492

[10] Gregson JM(2016)Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity Muscle Nerve Mar. 53 415-421